News

Reliance Life Sciences has obtained approval from the Drugs Controller General of India (DCGI) to carry out a Phase I clinical trial of its Covid-19 vaccine with some conditions. This trial will assess the safety, tolerability and immunogenicity of the...

Sorrento Therapeutics, Inc. announced the start of enrollment in its Phase 2 efficacy study of human allogeneic adipose-derived mesenchymal stem cells (COVI-MSC™) for patients suffering from COVID-19-induced acute respiratory distress (ARD) or acute respiratory distress syndrome (ARDS) in Brazil....

Dr.Reddy's Laboratories rose 0.71% to Rs 4934 after the company signed a deal with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox). In an exchange filing made on Saturday (4 September 2021), the drug maker...

The efficacy and safety of approved viral vector-based COVID-19 vaccines will not only stimulate further development in this area but also spotlights the importance of robust and scalable manufacturing solutions that can fully meet the demands for the clinical...

Gene therapies delivered using viral vectors offer exciting potential to welcome a new type of treatment for various disease indications. However, one of the most complex steps to develop and scale for viral vector transient production based on adenovirus...

Physiotherapy or Physical Therapy helps people recover from an injury, relieve pain, prevent future injury, or deal with a chronic condition; and now it has been noticed that it helps people overcome the after-effects of Covid-19 infections or related...

Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO), has announced that it has acquired Idifarma, a leading Contract Manufacturer of niche and highly potent generic and innovative drugs. The acquisition from Suanfarma delivers expansion across Southern Europe and...